Excellent 2022 10-K showing assiduous one step at a time return to 2018 $546K revenues as milestone amidst the external mitigating factors + Brexit+ Pandemic explained in full in MD&A .
Exceedingly transparent and LTIs prevalent to support the Company through Cure+ Super 10K+ Dismissal by ALJ+ Timely Filings+ Sponsoring Market Maker for Form 211+ Cleared FINRA —Next CE Removal+ Growth + NASDAQ